43548 Federal Register / Vol. 86, No. 150 / Monday, August 9, 2021 / Notices 

Broadcom from retaliating against a 

customer that refuses a prohibited 

majority share requirement or that 

purchases products from a competitor of 

Broadcom. 

Paragraph I of the proposed order 

defines the key terms used in the order. 

Paragraph II.A. of the proposed order 

prohibits Broadcom from imposing a 

majority share requirement on a 

customer’s purchases of any 

Monopolized Product. This provision is 

designed to end Broadcom’s exclusive 

dealing practices in the markets for 

Monopolized Products and to enable the 

emergence of effective competition in 

those markets. The prohibition applies 

to sales of Monopolized Products to 

OEMs and to U.S. service providers. The 

proposed order specifically includes 

prohibitions on Broadcom (1) 

conditioning the sale of a Monopolized 

Product on a majority share requirement 

for that product, (2) conditioning price 

terms, or non-price terms such as 

delivery or support terms, for a 

Monopolized Product on a majority 

share requirement for that product, (3) 

conditioning other payments on a 

majority share requirement for a 

Monopolized Product, or (4) providing 

certain types of retroactive rebates for a 

Monopolized Product in exchange for a 

majority share requirement. 

The prohibitions in Paragraph II.A. 

are qualified by a number of provisos 

designed to assure that the order does 

not bar Broadcom from competing on 

the merits. The first proviso clarifies 

that the order does not prohibit 

Broadcom from fulfilling orders from a 

customer that, over time, chooses to 

purchase more than 50% of its 

requirements from Broadcom, provided 

that such purchases are not pursuant to 

a majority share requirement prohibited 

by the order. The second proviso 

clarifies that a customer’s mere 

designation of Broadcom as an 

‘‘authorized’’ or ‘‘preferred’’ provider 

does not alone establish a violation of 

the order. The third proviso clarifies 

that the order does not prohibit nonretroactive volume discounts. The 

fourth proviso allows Broadcom, in 

narrow circumstances, to enter into a 

majority share requirement in 

connection with a particular request for 

proposal (RFP). The proviso provides 

that Broadcom may agree to a singlesource term in connection with an RFP 

covering a single device model (or a 

single device model and certain limited 

derivatives thereof) if the customer 

structures the RFP in this way. (In 

contrast, if a customer chooses to 

structure an RFP to split component 

supply for a particular device among 

multiple suppliers, Broadcom may not 

thwart this by insisting on exclusivity.) 

The fifth proviso enables Broadcom, in 

specified conditions, to agree to 

exclusivity terms with a customer to 

incent Broadcom to continue producing 

a product beyond its ordinary-course 

end of life. 

Paragraph II.B of the proposed order 

prohibits Broadcom from using its 

monopoly power in a Monopolized 

Product to impose majority share 

requirements for other Monopolized 

Products or Related Products. 

Paragraph II.C of the order prohibits 

Broadcom from retaliating against a 

customer for working with a Broadcom 

rival or for refusing to commit to or 

maintain a prohibited majority share 

requirement. Prohibited retaliation 

includes actual or threatened 

interference with the sale or delivery of 

Monopolized Products; withdrawal or 

modification of, or refusal to extend, 

relatively favorable price or non-price 

terms; or refusal to deal with the 

customer on terms generally available to 

other similarly situated customers. 

The proposed order contains standard 

provisions designed to ensure 

compliance. Paragraph III requires 

Broadcom to maintain an antitrust 

compliance program and to provide 

notice to customers of the prohibitions 

contained in the order. Paragraphs IV 

through VI contain provisions regarding 

compliance reports, notice of changes in 

respondent, and access to documents 

and personnel. 

The proposed Order’s prohibitions 

apply to agreements with Service 

Providers that serve end users in the 

United States and to agreements with 

OEMs worldwide, with the exception of 

agreements for the sale of products 

intended for use in devices for end users 

in China. These products are excluded 

from the prohibitions on majority share 

requirements in light of distinct 

competitive conditions applicable to 

them. The term of the proposed order is 

ten years. 

By direction of the Commission. 

Joel Christie, 

Acting Secretary. 

[FR Doc. 2021–16655 Filed 8–6–21; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting: Advisory Board on Radiation 

and Worker Health (ABRWH), 

Subcommittee for Dose 

Reconstruction Reviews (SDRR), 

National Institute for Occupational 

Safety and Health (NIOSH) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Subcommittee for Dose 

Reconstruction Reviews (SDRR) of the 

Advisory Board on Radiation and 

Worker Health (ABRWH or the Advisory 

Board). This meeting is open to the 

public, but without a public comment 

period. The public is welcome to submit 

written comments in advance of the 

meeting, to the contact person below. 

Written comments received in advance 

of the meeting will be included in the 

official record of the meeting. The 

public is also welcomed to listen to the 

meeting by joining the audio conference 

(information below). The audio 

conference line has 150 ports for callers. 

DATES: The meeting will be held on 

September 29, 2021, from 10:30 a.m. to 

4:00 p.m., EDT. Written comments must 

be received on or before September 22, 

2021. 

ADDRESSES: You may submit comments 

by mail to: Sherri Diana, National 

Institute for Occupational Safety and 

Health, 1090 Tusculum Avenue, MS 

C–34, Cincinnati, Ohio 45226. 

Meeting Information: Audio 

Conference Call via FTS Conferencing. 

The USA toll-free dial-in number is 

1–866–659–0537; the pass code is 

9933701. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, NIOSH, CDC, 1090 

Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone: 

(513) 533–6800; Toll Free 1(800)CDC– 

INFO; Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION:

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 150 / Monday, August 9, 2021 / Notices 43549 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction, which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program; and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to CDC. NIOSH implements 

this responsibility for CDC. 

The Advisory Board’s charter was 

issued on August 3, 2001, renewed at 

appropriate intervals, and rechartered 

under Executive Order 13889 on March 

22, 2020, and will terminate on March 

22, 2022. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. 

SDRR was established to aid the 

Advisory Board in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstruction. 

Matters To Be Considered: The agenda 

will include discussions on the 

following dose reconstruction program 

quality management and assurance 

activities: Dose reconstruction cases 

under review from Set 29, possibly 

including cases involving: Albuquerque 

Operations Office, Area IV of the Santa 

Susana Field Laboratory, Argonne 

National Laboratory-East, Argonne 

National Laboratory-West, Battelle 

Laboratories-King Avenue, Clarksville 

Modification Center, Feed Materials 

Production Center (FMPC), Fermi 

National Accelerator Laboratory, 

General Atomics, Hanford, Idaho 

National Laboratory, Lawrence Berkeley 

National Laboratory, Lawrence 

Livermore National Laboratory, Los 

Alamos National Laboratory, Mound 

Plant, Nevada Test Site, Oak Ridge 

Gaseous Diffusion Plant (K–25), Oak 

Ridge Institute for Science and 

Education, Oak Ridge National 

Laboratory (X–10), Pacific Northwest 

National Laboratory, Paducah Gaseous 

Diffusion Plant, Pantex Plant, 

Portsmouth Gaseous Diffusion Plant, 

Rocky Flats Plant, Savannah River Site, 

and/or Y–12 Plant. If time permits, there 

may also be discussion on professional 

judgement in response to the April 12, 

2021 SDRR report to the Advisory 

Board. Agenda items are subject to 

change as priorities dictate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–16954 Filed 8–6–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

Agency Information Collection 

Activities; Proposed Collection; Public 

Comment Request; Centers for 

Independent Living Program 

Performance Report (0985–0061) 

AGENCY: Administration for Community 

Living, Health and Human Services 

(HHS). 

ACTION: Notice. 

SUMMARY: The Administration for 

Community Living (ACL) is announcing 

an opportunity for the public to 

comment on the proposed collection of 

information listed above. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish a notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This Proposed Extension 

without Revision of a Currently 

Approved Collection (ICR Ext) solicits 

comments on the information collection 

requirements relating to the Centers for 

Independent Living under the 

Rehabilitation Act of 1973. 

DATES: Comments on the collection of 

information must be submitted 

electronically by 11:59 p.m. (EST) or 

postmarked by October 8, 2021. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to: Peter Nye at 

OILPPRAComments@acl.hhs.gov. 

Submit written comments on the 

collection of information to 

Administration for Community Living, 

Washington, DC 20201, Attention: Peter 

Nye. 

FOR FURTHER INFORMATION CONTACT: 

Peter Nye, Administration for 

Community Living, Washington, DC 

20024, (202) 795–7606 or 

OILPPRAComments@acl.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined 

in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA (44 

U.S.C. 3506(c)(2)(A)) requires Federal 

agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each proposed extension of an 

existing collection of information, 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, ACL is publishing a notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, ACL invites 

comments on our burden estimates or 

any other aspect of this collection of 

information, including: 

(1) Whether the proposed collection 

of information is necessary for the 

proper performance of ACL’s functions, 

including whether the information will 

have practical utility; 

(2) the accuracy of ACL’s estimate of 

the burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used 

to determine burden estimates; (3) ways 

to enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) ways to minimize the burden of 

the collection of information on 

respondents, including through the use 

of automated collection techniques 

when appropriate, and other forms of 

information technology. 


lotter on DSK11XQN23PROD with NOTICES1